Citra Nusantara Gemilang Tbk. vs Jayamas Medica Industri Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp154 (market cap 272.81B, 3.23M 24h volume), while Jayamas Medica Industri Tbk. trades at Rp208 (market cap 5.57T, 14.64M 24h volume). The key difference: Jayamas Medica Industri Tbk. is far larger — about 20.4× Citra Nusantara Gemilang Tbk.'s market cap, and Jayamas Medica Industri Tbk. is more actively traded (14.64M versus 3.23M). Which is the better fit depends on your goals.
| CGAS | OMED | |
|---|---|---|
Market Cap | 272.81B | 5.57T |
Volume | 3.23M | 14.64M |
Lot | 32.3K | 146.36K |
Turnover | 494.07M | 3.04B |
Average Price | 152.96 | 207.84 |
Value | 494.07M | 3.04B |
Indicative Equilibrium Price | 154 | 206 |
Indicative Equilibrium Volume | 94.2K | 700 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →